Precision Imaging to Evaluate Kaposi Sarcoma

AIMS 2 \& 3: In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.

NCT Number	NCT06898203
Lead Sponsor	Washington University School of Medicine Collaborators: National Cancer Institute (NCI), Pensievision, Kenya Medical Research Institute, Makerere University
Conditions	Kaposi Sarcoma
Enrollment	300 participants
Start Date	2026-04-10
Primary Completion	2028-11-30 (estimated)
Study Completion	2029-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-16